Biopharmaceuticals
News Release - August 19, 2016
Bayer and CRISPR Therapeutics joint venture, named Casebia Therapeutics, establishes operations in Cambridge, MA
Source: Bayer
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.